Skip to main content
. 2024 Feb 15;109(7):2219–2228. doi: 10.3324/haematol.2023.284089

Table 4.

Cycles, cumulative doses of selinexor, daratumumab, bortezomib and dexamethasone (S-DVd) and dose modifications in GEM Selibordara trial.

graphic file with name 1092219.tab4.jpg